EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $235,982 | -64.2% | 8,318 | -63.1% | 0.04% | -72.2% |
| Q4 2022 | $659,049 | -47.7% | 22,547 | -52.8% | 0.16% | -44.9% |
| Q3 2022 | $1,261,000 | +481.1% | 47,727 | +876.6% | 0.29% | +394.8% |
| Q2 2022 | $217,000 | -43.8% | 4,887 | -37.3% | 0.06% | -44.2% |
| Q1 2022 | $386,000 | +15.6% | 7,800 | +4.2% | 0.10% | -68.4% |
| Q4 2018 | $334,000 | -3.7% | 7,488 | +49.8% | 0.33% | +39.4% |
| Q3 2018 | $347,000 | +54.2% | 5,000 | +18.5% | 0.24% | +42.2% |
| Q4 2017 | $225,000 | – | 4,218 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |